Pennant Investors »

Altimmune shares owned by Pennant Investors

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 110k 10.18

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Altimmune

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Tang Capital Management
Susquehanna International
Geode Capital Management
Morgan Stanley
Knoll Capital Management
Goldman Sachs Group
Citadel Advisors
Bellevue Group
D. E. Shaw & Co
Nuveen Asset Management
Dimensional Fund Advisors

View all funds holding Altimmune